EP3332805
INNDÆLANLEGAR BÓTÚLÍN-EITURBLÖNDUR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.12.2009EP published:
23.2.2022EP application number:
18150826.8
EP translation filed:
3.5.2022Grant published:
15.7.2022EPO information:
European Patent Register
Max expiry date:
27.12.2029Expiry date:
27.12.2026Next due date:
31.12.2026
Title in English:
INJECTABLE BOTULINUM TOXIN FORMULATIONSLanguage of the patent:
English
Timeline
Today
28.12.2009EP application
23.2.2022EP Publication
3.5.2022Translation submitted
15.7.2022Registration published
27.12.2026Expires
Owner
Name:
ReVance Therapeutics, Inc.Address:
7555 Gateway Blvd., Newark, CA 94560, US
Inventor
Name:
RUEGG, Curtis, L.Address:
Redwood City, CA California 94062, US
Name:
STONE, Hongran, F.Address:
Menlo Park, CA California 94025, US
Name:
WAUGH, Jacob, M.Address:
San Francisco, CA California 94105, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
142063 PDate:
31.12.2008Country:
US
Classification
Categories:
A61K 39/08, A61K 8/64, A61Q 19/08
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 28.9.2022
Expires: 27.12.2023
Payer: Tego IP ehf.
Number: 15
Paid: 6.11.2023
Expires: 27.12.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 11.11.2024
Expires: 27.12.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 7.11.2025
Expires: 27.12.2026
Payer: Árnason Faktor ehf.